EUVIMEDEUVIMED entdecken
Crossref

Redox-triggered prodrug nanoassemblies with high tumor selectivity and biocompatibility break through antitumor dilemma of paclitaxel

Yaqi Li, Yixin Sun, Qinglong Yan, Wenjing Wang, Shuo Wang, Qing Wang, Danping Wang, Jun Yuan, Jin Sun, Zhonggui He, Zhenbao Li, Bingjun Sun

Chinese Chemical Letters · 2026-05 · 37 (5) · 111350

DOI: 10.1016/j.cclet.2025.111350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-05. Verfasst von Yaqi Li und 11 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Anhui University of Chinese Medicine, Department of Education of Liaoning Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • China Postdoctoral Science Foundation
  • Anhui University of Chinese Medicine
  • Department of Education of Liaoning Province
  • Liaoning Revitalization Talents Program
  • Key Research and Development Program of Liaoning Province

Zitieren

APA

Li, Y., Sun, Y., Yan, Q., Wang, W., Wang, S., Wang, Q., Wang, D., Yuan, J., Sun, J., He, Z., Li, Z., & Sun, B. (2026). Redox-triggered prodrug nanoassemblies with high tumor selectivity and biocompatibility break through antitumor dilemma of paclitaxel. Chinese Chemical Letters, 37(5), 111350. https://doi.org/10.1016/j.cclet.2025.111350

Vancouver

Li Y, Sun Y, Yan Q, Wang W, Wang S, Wang Q, et al. Redox-triggered prodrug nanoassemblies with high tumor selectivity and biocompatibility break through antitumor dilemma of paclitaxel. Chinese Chemical Letters. 2026;37(5):111350. doi:10.1016/j.cclet.2025.111350

BibTeX
@article{Li2026,
  author = {Li, Yaqi and Sun, Yixin and Yan, Qinglong and Wang, Wenjing and Wang, Shuo and Wang, Qing and Wang, Danping and Yuan, Jun and Sun, Jin and He, Zhonggui and Li, Zhenbao and Sun, Bingjun},
  title = {Redox-triggered prodrug nanoassemblies with high tumor selectivity and biocompatibility break through antitumor dilemma of paclitaxel},
  journal = {Chinese Chemical Letters},
  year = {2026},
  volume = {37},
  number = {5},
  pages = {111350},
  doi = {10.1016/j.cclet.2025.111350}
}
Kostenlos starten →